Kewan, Tariq http://orcid.org/0000-0003-4651-5125
Durmaz, Arda
Bahaj, Waled
Gurnari, Carmelo http://orcid.org/0000-0001-6829-5544
Terkawi, Laila
Awada, Hussein http://orcid.org/0000-0002-1445-7947
Ogbue, Olisaemeka D. http://orcid.org/0000-0001-9614-6626
Ahmed, Ramsha
Pagliuca, Simona
Awada, Hassan
Kubota, Yasuo
Mori, Minako http://orcid.org/0000-0003-4274-8714
Ponvilawan, Ben
Al-Share, Bayan
Patel, Bhumika J.
Carraway, Hetty E. http://orcid.org/0000-0001-5241-3614
Scott, Jacob
Balasubramanian, Suresh K.
Bat, Taha
Madanat, Yazan http://orcid.org/0000-0001-9573-2690
Sekeres, Mikkael A.
Haferlach, Torsten http://orcid.org/0000-0003-0196-2837
Visconte, Valeria http://orcid.org/0000-0002-2993-1509
Maciejewski, Jaroslaw P. http://orcid.org/0000-0002-6837-4346
Article History
Received: 26 October 2022
Accepted: 3 May 2023
First Online: 30 May 2023
Change Date: 8 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-024-45644-x
Competing interests
: Y.M. has received honoraria/consulting fees from BluePrint Medicines, GERON, OncLive and MD Education; participated in advisory boards and received honoraria from Sierra Oncology, Stemline Therapeutics, Blueprint Medicines, Morphosys, Taiho Oncology, Rigel Pharmaceuticals and Novartis; and received travel reimbursementfrom Blueprint Medicines, MD Education, and Morphosys. None of these relationships were related to this work. The remaining authors declare no competing interests.